Clinical trials
Observational Insulin Resistance trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
| Completed | 6 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| John Sievenpiper | 6 |
| Laval University | 2 |
| University of Toronto | 2 |
| Anthony Hanley | 1 |
| Becton, Dickinson and Company | 1 |
| Canadian Medical and Surgical Knowledge Translation Research Group | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Eli Lilly and Company | 1 |
| Hamilton Health Sciences Corporation | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 23 |
| Obesity | 11 |
| Metabolic Syndrome | 10 |
| Diabetes Mellitus | 9 |
| Prediabetic State | 9 |
| Body Weight | 7 |
| Cardiovascular Diseases | 7 |
| Overweight | 7 |
| Diabetes Mellitus, Type 2 | 5 |
| Dyslipidemias | 5 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.